SHARING OUR FINDINGS
Publications
We are committed to sharing the findings from our clinical trials and research & development activities through publications in peer-reviewed journals and at scientific conferences.
Latest publication
Banks et al
Birth Defects Research, 2023
Preclinical development of a novel Group B Streptococcus (GBS) vaccine candidate for maternal immunization based upon the alpha-like protein family of GBS surface proteins (Alp).
More publications
Dangor et al
Vaccine, 2023
Association of infant Rib and Alp1 surface protein N-terminal domain immunoglobulin G and invasive Group B Streptococcal disease in young infants.
Gonzalez-Miro et al
iScience, 2023
Safety and immunogenicity of the group B streptococcus vaccine AlpN in a placebo-controlled double-blind phase 1 trial.
Dominguez et Randis
Cell Reports Medicine (Commentary), 2022
Toward the development of a protein-based group B Streptococcus vaccine.
Pawlowski et al
Cell Reports Medicine, 2022
A group B Streptococcus alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains.
Fischer et al
Vaccine, 2021
Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women.
